On Thursday, the Food and Drug Administration said Eli Lilly's tirzepatide, sold as Zepbound for weightloss and Mounjaro to treat diabetes, is no longer in short supply. The FDA allows ...
The drugMounjaro (also known as tirzepatide ... you will lose weight.” In fact, he says, weightloss has shown to be more marked in those who do not have Type 2 diabetes.